The AI newswire
NEWTON, Mass. — March 26, 2025 — GV20 Therapeutics (GV20), a clinical-stage AI-powered biotherapeutics company, has entered into a strategic research collaboration with Mitsubishi Tanabe Pharma Corporation (MTPC). Under this…
Pheno.AI’s Human Phenotype Project (HPP) to Catalyze the Future of AI-Driven Health with Japanese Cohort TOKYO, Japan — March 26, 2025 — Corundum Systems Biology Inc. (CSB), a leading investment…
RESTON, Va. — March 26, 2025 — Cyberhill Partners, in partnership with data.world and KUNGFU.AI, has been awarded a contract with the Defense Innovation Unit (DIU) to develop a modernized…
TAIPEI, Taiwan — March 26, 2025 — AnHorn Medicines, a pioneering AI-driven new drug discovery company, is pleased to announce that, AH-001, a first-in-class protein degrader for androgenetic alopecia (AGA),…
New AI-driven automation, real-time analytics, and CRO Discovery capabilities eliminate inefficiencies, giving biotech companies more time and capital to focus on scientific breakthroughs. BOSTON, Mass. — March 25, 2025 —…
DARPA Backs Arzeda’s AI Platform to Create Novel Proteins with Limited Data SEATTLE, Wash. — January 23, 2025 — Arzeda, the industry-leading Protein Design Company™, today announced it has been…